120
Participants
Start Date
July 15, 2024
Primary Completion Date
August 1, 2026
Study Completion Date
August 1, 2026
Goserelin 3.6 MG
Goserelin acetate (Zoladex) is a gonadotropin-releasing hormone agonist (GnRH). GnRH agonists induce a transient increase in sex hormone concentrations, but subsequently inhibit gonadotropin secretion and the production of testosterone in men and estrogen in women. An equilibration period will occur to allow steroid concentrations to reduce.
Multi-Stressor Training
A 4-week physical training program that mimics military training.
Testosterone gel (AndroGel 5g)
Male subjects will be randomly assigned to receive a topical testosterone gel (5g dose).
Testosterone gel (AndroGel 1.25g)
Male subjects will be randomly assigned to receive a topical testosterone gel (1.25g dose).
Estradiol / Levonorgestrel Transdermal System [Climara Pro]
Female subjects will be randomly assigned to receive a estrogen/ progesterone patch.
Placebo Patch
Female subjects will be randomly assigned to receive a placebo patch identical to the Climara Pro patch.
RECRUITING
Neuromuscular Research Laboratory, Pittsburgh
U.S. Army Medical Research and Development Command
FED
Bradley Nindl
OTHER